BridgeBio Oncology Therapeutics, Inc. (BBOT) has an average rating of buy and mean price target of $25.30, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
SpaceX (SPCX) has an average rating of overweight and mean price target of $220.81, according to analysts polled by FactSet.Price: $219.24, Change: $-12.95, Percent Change: -5.58%
MGM Resorts International (MGM) has an average rating of overweight and mean price target of $48.91, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $46.81, Change: $-0.07, Percent Change: -0.15%
Crinetics Pharmaceuticals Inc (CRNX) has an average rating of overweight and mean price target of $83.18, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)